Joenja

two red lights
Pharma

FDA rejects new drug from Aquestive, expansion for Pharming

The FDA issued complete response letters to Aquestive Therapeutics and Pharming, resulting in vastly different reactions from the market.
Kevin Dunleavy Feb 2, 2026 11:30am
Novartis building

Pharming scores FDA nod for rare disease drug Joenja

Mar 27, 2023 11:06am